Microbiota metabolized Bile Acids accelerate Gastroesophageal Adenocarcinoma via FXR inhibition.
Theresa BaumeisterAndrea Proaño-VascoAmira MetwalyKarin KleigreweAlexander KuznetsovLinus SchömigMartin BorgmannMohammed KhiatAkanksha AnandKatrin BöttcherDirk HallerAndreas DunkelVeronika SomozaSinah ReiterChen MengRobert ThimmeRoland M SchmidDeepa T PatilElke BurgermeisterYiming HuangYiwei SunHarris H WangTimothy C WangJulian A AbramsMichael QuantePublished in: bioRxiv : the preprint server for biology (2024)
If its inhibition is linked to disease progression and its activation to cancer prevention, exploring the potential of FXR as a therapeutic target has great clinical relevance in GEAC context.